Innate Pharma S.A. (IPHA)

AI Score

Unlock

2.13

0.01 (0.47%)

At close: Mar 03, 2025, 3:59 PM

2.09

-1.88%

After-hours: Mar 03, 2025, 04:00 PM EST

Innate Pharma S.A. Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05
Cash & Equivalents	70.61M	84.22M	103.76M	136.79M	202.89M	152.31M	99.37M	175.91M	152.87M	64.29M	38.36M	30.58M	46.61M	31.82M	46.45M	10.88M	2.48M	6.16M	2.59M
Short-Term Investments	21.85M	17.26M	16.08M	14.85M	15.98M	15.22M	16.74M	21.78M	83.04M	4.95M	2.99M	2.03M	n/a	2.76M	2.75M	22.95M	48.3M	53.66M	15.76M
Long-Term Investments	9.8M	35.12M	39.88M	38.93M	37.01M	35.18M	60.47M	32.98M	37.79M	84K	272K	475K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	19.65M	14.25M	29.97M	30.09M	16.83M	87K	111K	355K	37.79M	84K	2K	n/a	692K	11K	10K	130K	6.04M	4.21M	2.85M
Receivables	15.23M	3.08M	846K	10.59M	2.82M	146.64M	15.08M	25.55M	9.95M	426K	1.99M	2.63M	n/a	5.11M	5.98M	13.86M	2.32M	2.43M	n/a
Inventory	n/a	-2K	-4.95M	1.00	5.6M	1.00	6.33M	513K	278K	1.49M	940K	1.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	40.32M	35.27M	17.57M	12.34M	15.92M	5.47M	6.33M	6.32M	5.99M	1.49M	6.19M	1.15M	581K	n/a	1.09M	4.36M	2.36M	2.02M	1.61M
Total Current Assets	148.01M	139.83M	138.26M	173.33M	237.6M	319.64M	137.52M	230.08M	252.13M	79.31M	49.35M	41M	52.98M	40.66M	56.27M	52.21M	55.59M	64.27M	21.21M
Property-Plant & Equipment	6.32M	8.54M	10.17M	11.69M	11.67M	10.22M	10.73M	9.09M	6.3M	5.93M	6.26M	6.82M	6.44M	7.33M	7.94M	8.52M	1.52M	774K	707K
Goodwill & Intangibles	416K	1.56M	44.19M	46.29M	96.97M	84.53M	46.19M	9.07M	9.73M	5.36M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	36.18M	68.03M	129.24M	134.09M	163.76M	131.57M	117.5M	51.5M	53.83M	11.38M	6.53M	7.3M	7.13M	7.35M	7.95M	8.65M	7.56M	4.98M	3.56M
Total Assets	184.19M	207.86M	267.5M	307.42M	401.36M	451.22M	255.02M	281.58M	305.96M	90.69M	55.88M	48.3M	60.11M	48.01M	64.22M	60.86M	63.15M	69.25M	24.77M
Account Payables	8.56M	13.66M	14.73M	20.73M	27.94M	28.58M	19.97M	15.6M	8.62M	6.85M	5.14M	4.67M	4.2M	5.03M	6.02M	6.58M	5.09M	2.9M	2.03M
Deferred Revenue	n/a	6.56M	12.5M	12.51M	48.77M	82.1M	47.91M	54.91M	-44.43M	885K	1.26M	7.66M	n/a	-688K	-550K	n/a	n/a	1.19M	597K
Short-Term Debt	8.94M	2.1M	30.75M	2.14M	2.13M	1.35M	1.34M	1.26M	622K	453K	613K	1.18M	2.27M	701K	n/a	n/a	n/a	585K	169K
Other Current Liabilities	15.12M	13.04M	14.45M	14.29M	35.99M	79.06M	283K	275K	10.01M	1.09M	1.43M	7.8M	9.02M	1.64M	3.24M	6.24M	5.46M	5.37M	-536K
Total Current Liabilities	39.64M	41.34M	79.89M	46.69M	121.82M	196.74M	73.91M	76.44M	60.16M	10.78M	9.28M	15.36M	15.49M	7.37M	9.27M	12.82M	10.55M	10.04M	2.26M
Long-Term Debt	30.96M	40.15M	13.5M	16.95M	16.59M	3.17M	4.52M	4.06M	3.13M	3.75M	4.21M	3.33M	4.5M	2.44M	2.45M	n/a	n/a	2.72M	411K
Other Long-Term Liabilities	61.7M	55.74M	36.23M	49.25M	3.9M	14.4M	3.63M	112.35M	170.59M	1.54M	2.11M	6.24M	13.49M	4.68M	5.38M	6.7M	3M	126K	2.03M
Total Long-Term Liabilities	92.66M	112.37M	80.17M	104.75M	62.12M	87.24M	95.16M	118.97M	173.73M	5.29M	6.32M	9.57M	17.99M	7.12M	7.83M	6.7M	3M	2.85M	2.44M
Total Liabilities	132.29M	153.71M	160.06M	151.45M	183.94M	283.98M	169.07M	195.41M	233.89M	16.06M	15.6M	24.93M	33.48M	14.49M	17.1M	19.52M	13.55M	12.89M	4.7M
Total Debt	39.89M	42.25M	44.25M	19.09M	18.72M	4.52M	5.86M	5.33M	3.75M	4.21M	4.82M	4.5M	13.22M	6.79M	7.55M	n/a	n/a	3.31M	580K
Common Stock	4.04M	4.01M	3.98M	3.95M	3.94M	3.2M	2.88M	2.7M	2.69M	2.65M	2.29M	1.9M	1.88M	1.88M	1.83M	1.3M	1.26M	1.25M	745K
Retained Earnings	-336.89M	-330.32M	-272.21M	-220.46M	-155.67M	-134.79M	-151.98M	-103.59M	-116.23M	-109.53M	-89.96M	-87.07M	-6.98M	-76.88M	-63.22M	-44.06M	-34.46M	-26.14M	-19.77M
Comprehensive Income	495K	819K	456K	355K	-472K	-1.1M	180K	-503K	-730K	-241K	-38K	-17K	n/a	341K	219K	n/a	n/a	n/a	n/a
Shareholders Equity	51.9M	54.15M	107.44M	155.97M	217.42M	167.24M	85.96M	86.17M	72.07M	74.63M	40.29M	23.36M	26.63M	33.52M	47.12M	41.34M	49.61M	56.37M	20.07M
Total Investments	31.65M	52.38M	55.96M	53.78M	52.98M	35.18M	60.47M	32.98M	37.79M	4.95M	272K	475K	692K	2.76M	2.75M	22.95M	48.3M	53.66M	15.76M